梅州妇科 专科医院(梅州开眼袋需要多少钱) (今日更新中)

President Donald Trump plans to announce his Supreme Court nominee on Saturday. He has said it will be a woman and she will be conservative.If the nominee goes through, it would give conservative justices a 6-3 majority over their more liberal counterparts.That sets up talk about abortion, but the Roe v. Wade debate isn't all about the Supreme Court.“Enough lower courts have not decided what they think about this,” said Carol Sanger, a professor at the Columbia law school. “We, the Supreme Court, doesn't like to lead on a particular issue until the lower courts who have trials and so on have thought about it.”Under a conservative majority, the Supreme Court has ruled on an abortion case. Conservative Chief Justice John Roberts sided with a ruling that kept abortion clinics open by not requiring abortion doctors to have nearby hospital admitting privileges.The high court already ruled on a similar case out of Texas.“There is a special doctrine called stare decisis, which means when you have a case and it’s like a previous case, look to that previous case and say how did that come out,” said Sanger. “And unless there is a very, very strong reason to change that decision, you follow precedent, you follow what happened the last time this issue came up.”Sanger says enough lower courts have to rule and be split on the decision to make it to the Supreme Court.The Supreme Court would need to decide it wants to take up Roe v. Wade before courts before them. Sanger believes that's unlikely to happen.“It seems pretty clear that he doesn't want to be known as the guy who had Roe knocked out under his chief justice-ship,” said Sanger.Both Justices Kavanaugh and Gorsuch said they accepted Roe v. Wade as the law of the land during their nomination hearings.Sanger says just because the justices on the court change, it doesn't mean they change laws all over again. 1887

President Donald Trump laid out his health care agenda Thursday amid a global pandemic and growing uncertainty about the future of the Affordable Care Act, the Obama-era law he vowed to replace with a much better plan, but never did. In a campaign-style visit to swing state North Carolina, the president sketched out what aides call a “vision” for quality health care at affordable prices, lower prescription drug costs and greater consumer choice. Although the Trump administration has made some progress on his health care goals, the major changes he promised have eluded him. And the clock has all but run out in Congress.Among one of the points highlighted in his executive order was his promise to make preexisting conditions covered by insurance companies. But this point is already covered by the Affordable Care Act, which the Trump administration is working to get overturned in the federal courts. 920

President Donald Trump called for reforming background checks for gun purchases in a tweet on Tuesday night."Whether we are Republican or Democrat, we must now focus on strengthening Background Checks!" the President tweeted.Trump's tweet comes amid a renewed call on lawmakers for legislation surrounding guns after 17 people were killed last week at Marjory Stoneman Douglas High School in Florida.On Monday, White House principal deputy press secretary Raj Shah indicated in a statement that Trump was open to making changes to the background check system. 567

President Donald Trump has received at least eight different medicines and supplements since he was diagnosed with COVID-19.Several are new and approved under emergency or compassionate use orders, including Regeneron's antibody cocktail. It uses lab-created COVID-19 antibodies to boost the immune response.A late stage trial that has not been peer-reviewed yet suggests the cocktail is safe and appeared to reduce symptoms.“None of the other medicines that he's been given, whether it's Remdesivir, more recently, dexamethasone, none of them have actually been shown to have direct antiviral activity, that is, they don't lower the virus levels directly,” said Dr. George Yancopoulos, a founding scientist at Regeneron.Yancopoulos says they're getting more requests, but “compassionate use” is not intended for widespread distribution. The Food and Drug Administration would have to grant emergency use authorization“And as of course, we all know, when you're fighting a viral disease and it's a race between the virus taking over and your body beating it, and dropping viral levels would be a great indicator that that the battle is going in the right direction and that the patient is winning,” said Yancopoulos.The president also took a steroid called dexamethasone. It's used to treat inflammation and is proven to help people breathe when they need oxygen.“For patients who were hospitalized or getting oxygen, it was extremely effective in helping them walk out of the hospital under their own powers,” said Peter Pitts, President of the Center for Medicine in the Public Interest.Meanwhile first lady Melania Trump, who also tested positive, tweeted Monday that she is feeling good and will continue to rest at home. 1733

Prescription drug ads are on every channel, and with them come the laundry list of side effects tacked on at the end of every TV spot. Now, in addition to listing those side effects, you could soon be hearing about the costs.A new proposal from the Trump administration would force manufacturers to state a drug's list price in any TV advertisement.It was a goal first laid out by Human and Health Services Secretary Alex Azar back in May."If we wanna have a real market for drugs, why not have them disclose their prices in the ads too?” asked Azar. “Consumers would have more balanced info and companies would have incentives for setting their prices…"Experts on drug pricing, like John Hopkins University's Gerard Anderson, say it’s about time."If you’re buying a TV, they'll tell you what a TV costs. If the grocery store’s having a sale, they’ll say how much oranges cost. This is something that should be and is just long overdue in the pharma industry,” Anderson says.Pharmaceutical companies have pushed back via their trade group, which said that posting prices on TV could be "misleading or confusing.” Their proposal was to, instead, tell consumers that pricing information could be found on the drug's website."The problem is that most of us would never go to their website to look up that information,” Anderson explains. “And the FDA would have to monitor closely the info on their site and that could change daily. So, it’s really not a viable option."The proposal will be open for public comment for 60 days, and even if it goes into effect after that, industry experts say they're likely to face many legal challenges from the pharmaceutical industry. 1676

来源：资阳报